Jeremy Levin's metamorphosis continues as Ovid's CEO

Jeremy Levin, the former CEO of Teva, is continuing his career transformation into biotech by taking up the position of chief executive officer at the private New York-based firm Ovid Therapeutics. Dr Levin was appointed Ovid's chairman last year and will continue to serve in this role.